CD8A and neoplasm: Data from in vivo mouse studies show that the antigen presentation to CD8+ T cells requires MHC I on host APCs and is independent of sEV MHC I (94, 95), reiterating the importance of host immune cell interactions in B cell sEV-mediated CTL induction, a key step to enhance anti-tumor immunity.